Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status: A pilot study

Luisella Vigna, Giuseppe Solimena, Fabrizia Bamonti, Marina Arcaro, Chiara Fenoglio, Emanuela Oldoni, Cinzia Dellanoce, Paola Rossi, Francesca Gori, Rocco Figliola, Giuliana Cighetti

Research output: Contribution to journalArticle

Abstract

Alpha-lipoic acid (α-LA), an endogenous antioxidant co-factor of important enzymatic complexes, is rapidly catabolised in dihydrolipoic acid becoming an even stronger antioxidant for strengthening the activity of endogenous antioxidants (vitamin C, E, glutathione). AIM. To evaluate the effects of an oral use liquid formulation containing the natural and more active α-lipoic acid (R-αLA) enantiomer on 20 subjects oxidative status: 10 apparently healthy subjects and 10 affected by risk factors (such as excess weight, hypertension) and/or diseases (such as diabetes, polyneuropathy). The subjects' oxidative status was assessed by measuring blood concentrations of: reactive oxygen species (ROS), total antioxidant capacity (TAC), glutathione, Vitamin C and Vitamin E at baseline (T0) and after 1-month' supplementation (T1) with R-αLA. Moreover, cysteine and homocysteine levels, well-known cardiovascular risk factors, were measured. Results. Interesting findings on the cellular antioxidant regeneration cycle: a significant decrease in reduced glutathione (GSH) levels and GSH/GSSG ratio, a slight downward trend in oxidised glutathione (GSSG) and vitamin C and E concentrations. Due to the brief treatment period, the study did not however show any significant differences in the oxidative "status" balancing parameters (ROS and TAC) and on homocysteine and cysteine levels. Remarkable were the findings regarding patients who reported a lessening, or even the disappearance, of pain symptoms. Comment. After 1-month' treatment, the R-αLA oral use liquid formulation seemed to reinforce endogenous antioxidant activity and, notably, helped mitigate the pain symptoms typical of several stress oxidative-dependent diseases. This effect could probably depend on greater bioavailability of the liquid formulation.

Original languageEnglish
Pages (from-to)14-25
Number of pages12
JournalProgress in Nutrition
Volume19
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

lipoic acid
Thioctic Acid
Antioxidants
glutathione
antioxidants
Glutathione Disulfide
ascorbic acid
homocysteine
Vitamin E
Ascorbic Acid
Glutathione
signs and symptoms (animals and humans)
liquids
cysteine
vitamin E
pain
reactive oxygen species
mouth
risk factors
antioxidant activity

Keywords

  • Glutathione
  • Inflammatory diseases
  • Oxidative status
  • α-lipoic acid

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status : A pilot study. / Vigna, Luisella; Solimena, Giuseppe; Bamonti, Fabrizia; Arcaro, Marina; Fenoglio, Chiara; Oldoni, Emanuela; Dellanoce, Cinzia; Rossi, Paola; Gori, Francesca; Figliola, Rocco; Cighetti, Giuliana.

In: Progress in Nutrition, Vol. 19, No. 1, 2017, p. 14-25.

Research output: Contribution to journalArticle

Vigna, L, Solimena, G, Bamonti, F, Arcaro, M, Fenoglio, C, Oldoni, E, Dellanoce, C, Rossi, P, Gori, F, Figliola, R & Cighetti, G 2017, 'Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status: A pilot study', Progress in Nutrition, vol. 19, no. 1, pp. 14-25. https://doi.org/10.23751/pn.v19i1.6325
Vigna, Luisella ; Solimena, Giuseppe ; Bamonti, Fabrizia ; Arcaro, Marina ; Fenoglio, Chiara ; Oldoni, Emanuela ; Dellanoce, Cinzia ; Rossi, Paola ; Gori, Francesca ; Figliola, Rocco ; Cighetti, Giuliana. / Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status : A pilot study. In: Progress in Nutrition. 2017 ; Vol. 19, No. 1. pp. 14-25.
@article{53917d40782f45b1877fbe2aa5966e0e,
title = "Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status: A pilot study",
abstract = "Alpha-lipoic acid (α-LA), an endogenous antioxidant co-factor of important enzymatic complexes, is rapidly catabolised in dihydrolipoic acid becoming an even stronger antioxidant for strengthening the activity of endogenous antioxidants (vitamin C, E, glutathione). AIM. To evaluate the effects of an oral use liquid formulation containing the natural and more active α-lipoic acid (R-αLA) enantiomer on 20 subjects oxidative status: 10 apparently healthy subjects and 10 affected by risk factors (such as excess weight, hypertension) and/or diseases (such as diabetes, polyneuropathy). The subjects' oxidative status was assessed by measuring blood concentrations of: reactive oxygen species (ROS), total antioxidant capacity (TAC), glutathione, Vitamin C and Vitamin E at baseline (T0) and after 1-month' supplementation (T1) with R-αLA. Moreover, cysteine and homocysteine levels, well-known cardiovascular risk factors, were measured. Results. Interesting findings on the cellular antioxidant regeneration cycle: a significant decrease in reduced glutathione (GSH) levels and GSH/GSSG ratio, a slight downward trend in oxidised glutathione (GSSG) and vitamin C and E concentrations. Due to the brief treatment period, the study did not however show any significant differences in the oxidative {"}status{"} balancing parameters (ROS and TAC) and on homocysteine and cysteine levels. Remarkable were the findings regarding patients who reported a lessening, or even the disappearance, of pain symptoms. Comment. After 1-month' treatment, the R-αLA oral use liquid formulation seemed to reinforce endogenous antioxidant activity and, notably, helped mitigate the pain symptoms typical of several stress oxidative-dependent diseases. This effect could probably depend on greater bioavailability of the liquid formulation.",
keywords = "Glutathione, Inflammatory diseases, Oxidative status, α-lipoic acid",
author = "Luisella Vigna and Giuseppe Solimena and Fabrizia Bamonti and Marina Arcaro and Chiara Fenoglio and Emanuela Oldoni and Cinzia Dellanoce and Paola Rossi and Francesca Gori and Rocco Figliola and Giuliana Cighetti",
year = "2017",
doi = "10.23751/pn.v19i1.6325",
language = "English",
volume = "19",
pages = "14--25",
journal = "Progress in Nutrition",
issn = "1129-8723",
publisher = "Mattioli 1885 S.p.A.",
number = "1",

}

TY - JOUR

T1 - Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status

T2 - A pilot study

AU - Vigna, Luisella

AU - Solimena, Giuseppe

AU - Bamonti, Fabrizia

AU - Arcaro, Marina

AU - Fenoglio, Chiara

AU - Oldoni, Emanuela

AU - Dellanoce, Cinzia

AU - Rossi, Paola

AU - Gori, Francesca

AU - Figliola, Rocco

AU - Cighetti, Giuliana

PY - 2017

Y1 - 2017

N2 - Alpha-lipoic acid (α-LA), an endogenous antioxidant co-factor of important enzymatic complexes, is rapidly catabolised in dihydrolipoic acid becoming an even stronger antioxidant for strengthening the activity of endogenous antioxidants (vitamin C, E, glutathione). AIM. To evaluate the effects of an oral use liquid formulation containing the natural and more active α-lipoic acid (R-αLA) enantiomer on 20 subjects oxidative status: 10 apparently healthy subjects and 10 affected by risk factors (such as excess weight, hypertension) and/or diseases (such as diabetes, polyneuropathy). The subjects' oxidative status was assessed by measuring blood concentrations of: reactive oxygen species (ROS), total antioxidant capacity (TAC), glutathione, Vitamin C and Vitamin E at baseline (T0) and after 1-month' supplementation (T1) with R-αLA. Moreover, cysteine and homocysteine levels, well-known cardiovascular risk factors, were measured. Results. Interesting findings on the cellular antioxidant regeneration cycle: a significant decrease in reduced glutathione (GSH) levels and GSH/GSSG ratio, a slight downward trend in oxidised glutathione (GSSG) and vitamin C and E concentrations. Due to the brief treatment period, the study did not however show any significant differences in the oxidative "status" balancing parameters (ROS and TAC) and on homocysteine and cysteine levels. Remarkable were the findings regarding patients who reported a lessening, or even the disappearance, of pain symptoms. Comment. After 1-month' treatment, the R-αLA oral use liquid formulation seemed to reinforce endogenous antioxidant activity and, notably, helped mitigate the pain symptoms typical of several stress oxidative-dependent diseases. This effect could probably depend on greater bioavailability of the liquid formulation.

AB - Alpha-lipoic acid (α-LA), an endogenous antioxidant co-factor of important enzymatic complexes, is rapidly catabolised in dihydrolipoic acid becoming an even stronger antioxidant for strengthening the activity of endogenous antioxidants (vitamin C, E, glutathione). AIM. To evaluate the effects of an oral use liquid formulation containing the natural and more active α-lipoic acid (R-αLA) enantiomer on 20 subjects oxidative status: 10 apparently healthy subjects and 10 affected by risk factors (such as excess weight, hypertension) and/or diseases (such as diabetes, polyneuropathy). The subjects' oxidative status was assessed by measuring blood concentrations of: reactive oxygen species (ROS), total antioxidant capacity (TAC), glutathione, Vitamin C and Vitamin E at baseline (T0) and after 1-month' supplementation (T1) with R-αLA. Moreover, cysteine and homocysteine levels, well-known cardiovascular risk factors, were measured. Results. Interesting findings on the cellular antioxidant regeneration cycle: a significant decrease in reduced glutathione (GSH) levels and GSH/GSSG ratio, a slight downward trend in oxidised glutathione (GSSG) and vitamin C and E concentrations. Due to the brief treatment period, the study did not however show any significant differences in the oxidative "status" balancing parameters (ROS and TAC) and on homocysteine and cysteine levels. Remarkable were the findings regarding patients who reported a lessening, or even the disappearance, of pain symptoms. Comment. After 1-month' treatment, the R-αLA oral use liquid formulation seemed to reinforce endogenous antioxidant activity and, notably, helped mitigate the pain symptoms typical of several stress oxidative-dependent diseases. This effect could probably depend on greater bioavailability of the liquid formulation.

KW - Glutathione

KW - Inflammatory diseases

KW - Oxidative status

KW - α-lipoic acid

UR - http://www.scopus.com/inward/record.url?scp=85020444568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020444568&partnerID=8YFLogxK

U2 - 10.23751/pn.v19i1.6325

DO - 10.23751/pn.v19i1.6325

M3 - Article

AN - SCOPUS:85020444568

VL - 19

SP - 14

EP - 25

JO - Progress in Nutrition

JF - Progress in Nutrition

SN - 1129-8723

IS - 1

ER -